ClinicalTrials.gg
Status unknownNCT01393587Updated Jul 18, 2012

A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

An interventional study of Taking blood samples in Oxidative Stress and Laproscopy, sponsored by Western Galilee Hospital-Nahariya. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-18.

Sponsored by Western Galilee Hospital-Nahariya · Not applicable and Interventional

The sponsor has not verified this record recently (last verified Jul 2011), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Ages
18 Years and older
Sex
All
01

Study summary

Recently, a new synthetic marker was developed, based on a molecule that is composed of Amino Acids and Linoleic Acid and Neucleic Acid, which is capable of detecting even minor changes of oxidative stress.

The investigators would like to assess the usefulness of this marker during positive pressure pneumoperitoneum, during laproscopic surgery, with or without intenstinal resection (ischemia induced by intra-abdominal pressure and vascualr compromise).

02

Conditions studied

  • Oxidative Stress
  • Laproscopy

Keywords

  • Oxidative Stress
  • Laproscopy
03

In context

Lead sponsor

Western Galilee Hospital-Nahariya is the lead sponsor of 89 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy patients undergoing elective laproscopic cholecystectomy and patients undergoing operation for tumer of large intenstine.

Exclusion criteria

Exclusion Criteria:

  • Patients suffering from Cardio Pulmonory and renal diseases
05

Study design

Phase
Not applicable

Study arms

  • Experimental
    Experimental

    Procedure: Taking blood samples

Interventions

  • ProcedureTaking blood samples
06

Study locations

1 site
  • Western Galilee Hospital
    Nahariya, 22100, Israel
    • Amitai Bickel, Dr. · Principal investigator
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01393587
Lead sponsor
Western Galilee Hospital-Nahariya
Collaborators
Migal, Galilee Technology Center
First posted
Jul 13, 2011
Last update
Jul 18, 2012

Study contacts

Amitai Bickel, Dr.
Contact
amitai@netvision.net.il
+972-507887554 ext. 7554
Y Mosenzon, M.A
Contact
yael.mosenzon@naharia.health.gov.il
+972-49107011 ext. 7022
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion